Whole-Blood 3-Gene Signature as a Decision Aid for Rifapentine-based Tuberculosis Preventive Therapy. Huang HL, Lee JY, Lo YS, Liu IH, et al. Clin Infect Dis 2022;75:743-752.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang HL, Lee JY, Lo YS, Liu IH, et al. Whole-Blood 3-Gene Signature as a Decision Aid for Rifapentine-based Tuberculosis Preventive Therapy. Clin Infect Dis 2022;75:743-752.
PMID: 34989801